Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2018) Vol. 94, Iss. 3, pp. 363-377
Closed Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1676
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
Daniel J. DeAngelo, Deepti Radia, Tracy I. George, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2183-2191
Open Access | Times Cited: 106
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
Jason Gotlib, Andreas Reiter, Deepti Radia, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2192-2199
Open Access | Times Cited: 105
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis
Andreas Reiter, Tracy I. George, Jason Gotlib
Blood (2020) Vol. 135, Iss. 16, pp. 1365-1376
Open Access | Times Cited: 112
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
Mohamad Jawhar, Juliana Schwaab, Iván Álvarez‐Twöse, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 31, pp. 2846-2856
Open Access | Times Cited: 103
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?
Theoharis C. Theoharides, Irene Tsilioni, Huali L. Ren
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 6, pp. 639-656
Open Access | Times Cited: 101
Histiocytosis
Jean‐François Emile, F. Cohen Aubart, Matthew Collin, et al.
The Lancet (2021) Vol. 398, Iss. 10295, pp. 157-170
Open Access | Times Cited: 89
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management
Catherine R. Weiler, K. Frank Austen, Cem Akin, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 4, pp. 883-896
Open Access | Times Cited: 86
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1286-1306
Closed Access | Times Cited: 28
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021
Magdalena Lange, Karin Hartmann, Melody C. Carter, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2586-2586
Open Access | Times Cited: 54
The challenges of chronic pain and fatigue
Jessica Eccles, Kevin L. Davies
Clinical Medicine (2021) Vol. 21, Iss. 1, pp. 19-27
Open Access | Times Cited: 46
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
Julij Šelb, Matija Rijavec, Renato Eržen, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 2, pp. 621-626.e7
Open Access | Times Cited: 41
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis
Johannes Lübke, Juliana Schwaab, Nicole Naumann, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 16, pp. 1783-1794
Open Access | Times Cited: 33
Clonal mast cell disorders and hereditary α‐tryptasemia as risk factors for anaphylaxis
Mark Kačar, Matija Rijavec, Julij Šelb, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 4, pp. 392-404
Open Access | Times Cited: 21
Mast Cells in Cardiovascular Disease: From Bench to Bedside
Maud A.W. Hermans, Jeanine E. Roeters van Lennep, Paul Van Daele, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3395-3395
Open Access | Times Cited: 52
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis
Benedetta Sordi, Fiorenza Vanderwert, Francesca Crupi, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 485-493.e11
Closed Access | Times Cited: 26
Mast Cells and Vitamin D Status: A Clinical and Biological Link in the Onset of Allergy and Bone Diseases
Giuseppe Murdaca, Alessandro Allegra, Alessandro Tonacci, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1877-1877
Open Access | Times Cited: 25
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial
Frank Siebenhaar, Sabine Altrichter, Hanna Bonnekoh, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 5, pp. 511-519
Closed Access | Times Cited: 16
Elevated Serum Tryptase in Non-Anaphylaxis Cases: A Concise Review
Adrian Y. S. Lee
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 5, pp. 357-364
Open Access | Times Cited: 35
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
Joseph H. Butterfield, Catherine R. Weiler
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 8, pp. 2533-2541
Closed Access | Times Cited: 33
Mast Cell Activation Disorders
Arianna Giannetti, Emanuele Filice, Carlo Caffarelli, et al.
Medicina (2021) Vol. 57, Iss. 2, pp. 124-124
Open Access | Times Cited: 27
KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes
Paula Navarro‐Navarro, Iván Álvarez‐Twöse, Alba Pérez‐Pons, et al.
Allergy (2022) Vol. 78, Iss. 5, pp. 1347-1359
Open Access | Times Cited: 21
Characterization of patients with clonal mast cells in the bone marrow with clinical significance not otherwise specified
Thomas Ballul, Vito Sabato, Peter Valent, et al.
EClinicalMedicine (2025) Vol. 80, pp. 103043-103043
Open Access
Mastocitosis
C. Bulaï Livideanu, C. El-Samrout, Nicolas Gaudenzio
EMC - Dermatología (2025) Vol. 59, Iss. 1, pp. 1-15
Closed Access
Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis
Catherine R. Weiler
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 8, Iss. 2, pp. 498-506
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top